The Valley Desk

NCT03399448 · Interventional trial

NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)

Overall registry status Terminated

Phase 1

Conditions Melanoma, Multiple Myeloma, Myxoid/Round Cell Liposarcoma, Synovial Sarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov